Literature DB >> 18179928

Cyclosporine A prevents apoptosis-related mitochondrial dysfunction after neonatal cardioplegic arrest.

Norihiko Oka1, Lixing Wang, Wenyu Mi, Wei Zhu, Osami Honjo, Christopher A Caldarone.   

Abstract

OBJECTIVE: Mitochondrial permeability transition pore opening plays a critical role in mediating the mitochondrial response to ischemia/reperfusion injury and initiation of apoptosis. We tested whether inhibition of mitochondrial permeability transition pore opening with cyclosporine A prevented apoptosis-related alterations in mitochondrial structure and function after cardioplegic arrest.
METHODS: Newborn piglets (age approximately 14 days) underwent cardiopulmonary bypass, cardioplegic arrest (60 minutes), weaning from bypass, and 6-hour reperfusion. Comparison was made among cold crystalloid cardioplegia (n = 5), cold crystalloid cardioplegia with cyclosporine A pretreatment (n = 5), and noncardiopulmonary bypass (n = 5) groups.
RESULTS: Early apoptosis signaling events (Bax translocation to the mitochondria) were prominent in cold crystalloid cardioplegia and prevented in cold crystalloid cardioplegia + cyclosporine A myocardium. Mitochondrial release of cytochrome c, determined by Western blot of cytosolic fractions and confocal quantitative colocalization analysis, was also prominent in cold crystalloid cardioplegia but prevented in cold crystalloid cardioplegia + cyclosporine A myocardium. Electron microscopy of isolated mitochondria demonstrated subjective alterations in mitochondrial architecture in cold crystalloid cardioplegia mitochondria, which were prevented by cyclosporine A. Deficiency of isolated mitochondrial oxygen consumption at Complex I was present in cold crystalloid cardioplegia mitochondria and prevented by cyclosporine A (P < .01). The frequency of deoxyuride-5'-triphosphate biotin nick end labeling-positive myocytes was diminished in cold crystalloid cardioplegia + cyclosporine A myocardium (P < .05). Mitochondrial resistance to calcium-mediated mitochondrial permeability transition pore opening was not different in cold crystalloid cardioplegia and noncardiopulmonary bypass mitochondria, suggesting that calcium overload is not solely responsible for the observed deficits in mitochondrial function.
CONCLUSIONS: Cyclosporine A pretreatment prevents postcardioplegia alterations in mitochondrial structure and function in a clinically relevant model of neonatal cardiac surgery. Prevention of mitochondrial permeability transition pore opening and apoptosis signaling events (Bax translocation and mitochondrial permeabilization) are associated with superior mitochondrial preservation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18179928     DOI: 10.1016/j.jtcvs.2007.05.009

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  16 in total

Review 1.  Mitochondria are sources of metabolic sink and arrhythmias.

Authors:  Fadi G Akar; Brian O'Rourke
Journal:  Pharmacol Ther       Date:  2011-04-14       Impact factor: 12.310

Review 2.  Cardiac mitochondria and arrhythmias.

Authors:  David A Brown; Brian O'Rourke
Journal:  Cardiovasc Res       Date:  2010-07-09       Impact factor: 10.787

3.  Gefitinib induces apoptosis in human glioma cells by targeting Bad phosphorylation.

Authors:  Cheng-Yi Chang; Chiung-Chyi Shen; Hong-Lin Su; Chun-Jung Chen
Journal:  J Neurooncol       Date:  2011-07-09       Impact factor: 4.130

4.  One dose of cyclosporine A is protective at initiation of folic acid-induced acute kidney injury in mice.

Authors:  Xiaoyan Wen; Zhiyong Peng; Yingjian Li; Hongzhi Wang; Jeffrey V Bishop; Lisa R Chedwick; Kai Singbartl; John A Kellum
Journal:  Nephrol Dial Transplant       Date:  2012-01-31       Impact factor: 5.992

5.  Cyclosporine A cardioprotection: mechanisms and potential for clinical application.

Authors:  Rolf Bünger; Robert T Mallet
Journal:  Crit Care Med       Date:  2013-04       Impact factor: 7.598

6.  Perioperative mechanical circulatory support in children: an analysis of the Society of Thoracic Surgeons Congenital Heart Surgery Database.

Authors:  Christopher E Mascio; Erle H Austin; Jeffrey P Jacobs; Marshall L Jacobs; Amelia S Wallace; Xia He; Sara K Pasquali
Journal:  J Thorac Cardiovasc Surg       Date:  2013-11-16       Impact factor: 5.209

7.  Intra-Coronary Administration of Tacrolimus Improves Myocardial Perfusion and Left Ventricular Function in Patients with ST-Segment Elevation Myocardial Infarction (COAT-STEMI) Undergoing Primary Percutaneous Coronary Intervention.

Authors:  Pei-Hsun Sung; Wei-Chun Huang; Ting-Hsing Chao; Cheng-Han Lee; Teng-Yao Yang; Yu-Sheng Lin; Rei-Yeuh Chang; Jun-Ted Chong; Cheng-Hsu Yang; Chieh-Jen Chen; Sheng-Ying Chung; Shu-Kai Hsueh; Chiung-Jen Wu; Hon-Kan Yip
Journal:  Acta Cardiol Sin       Date:  2021-05       Impact factor: 2.672

Review 8.  Translocator protein (18 kDa): a promising therapeutic target and diagnostic tool for cardiovascular diseases.

Authors:  Xiaolong Qi; Jiahong Xu; Fei Wang; Junjie Xiao
Journal:  Oxid Med Cell Longev       Date:  2012-11-28       Impact factor: 6.543

9.  Coronary flow and reactivity, but not arrhythmia vulnerability, are affected by cardioplegia during cardiopulmonary bypass in piglets.

Authors:  Petru Liuba; Sune Johansson; Erkki Pesonen; Michal Odermarsky; Axel Kornerup-Hansen; Anders Forslid; Elhadi H Aburawi; Thomas Higgins; Malene Birck; Valeria Perez-de-Sa
Journal:  J Cardiothorac Surg       Date:  2013-06-19       Impact factor: 1.637

Review 10.  Is further improvement of the treatment of acute coronary syndromes still possible?

Authors:  Marek Jerzy Dąbrowski
Journal:  Postepy Kardiol Interwencyjnej       Date:  2013-03-21       Impact factor: 1.426

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.